Status:
UNKNOWN
Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery
Lead Sponsor:
Mahidol University
Conditions:
Colorectal Cancer
Bowel Ileus
Eligibility:
All Genders
15-70 years
Phase:
NA
Brief Summary
Postoperative ileus (POI) is one of the most common causes of prolonged hospital stays after abdominal surgery. The pathophysiology of POI is multifactorial and complex.It is known to be associated wi...
Detailed Description
This prospective blinded (participants,researchers,investigators) randomizedcontrolledtrial (RCT) is aimed to study the efficacy of the prokinetic agents, specifically, Mosapride on gastrointestinal r...
Eligibility Criteria
Inclusion
- Patients who are undergoing elective colorectal cancer surgery at Ramathibodi hospital both open and laparoscopic surgery.
- Both male and female who age between 15 to 70 years old.
- Physical status American Society of Anesthesiologists (ASA) classification1-2-3.
Exclusion
- Metastatic disease.
- Patients who reject to participate or withdrawal from the research.
- History of Mosapride allergy.
- Pregnancy.
- Emergency colorectal cancer surgery.
- Intestinal perforation or obstruction.
- Patients who have cardiac problem (Side effects of Mosapride may include arrhythmia or QTprolong).
- Physical status American Society of Anesthesiologists (ASA) classification 4-5.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2023
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT04905147
Start Date
July 1 2021
End Date
November 30 2023
Last Update
September 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chairat Supsamutchai
Bangkok, Bankok, Thailand, 10400